• Agree Realty Corporation: JMP Securities downgrades to market perform from market outperform.
  • Avalonbay Communities, Inc.: JP Morgan upgrades to overweight from neutral with a price target raised from USD 247 to USD 262.
  • Camden Property Trust: JP Morgan downgrades to underweight from neutral with a target price reduced from USD 129 to USD 128.
  • Cardinal Health, Inc.: Morgan Stanley maintains its overweight rating with a price target raised from USD 127 to USD 136.
  • Chubb Limited: Piper Sandler & Co upgrades to overweight from dropped coverage with a target price raised from USD 305 to USD 312.
  • Cloudflare, Inc.: Stifel upgrades to buy from hold with a price target raised from USD 95 to USD 136.
  • Cousins Properties Incorporated: KeyBanc Capital Markets upgrades to overweight from underweight with a price target raised from USD 19 to USD 34.
  • Eastgroup Properties, Inc.: KeyBanc Capital Markets downgrades to sector weight from overweight.
  • Ecolab Inc.: BMO Capital Markets upgrades to outperform from market perform and raises the target price from USD 279 to USD 290.
  • Essex Property Trust, Inc.: JP Morgan downgrades to underweight from neutral with a target price raised from USD 297 to USD 303.
  • First Industrial Realty Trust, Inc.: KeyBanc Capital Markets upgrades to sector weight from underweight.
  • Labcorp Holdings Inc.: Morgan Stanley maintains its overweight rating with a target price raised from USD 260 to USD 270.
  • Martin Marietta Materials, Inc.: Morgan Stanley maintains its overweight rating with a reduced target price from USD 657 to USD 622.
  • Match Group, Inc.: Jefferies downgrades to hold from buy with a target price reduced from USD 40 to USD 32.
  • Ppg Industries, Inc.: KeyBanc Capital Markets downgrades to sector weight from overweight.
  • Tesla, Inc.: Mizuho Securities upgrades to outperform from neutral with a price target raised from USD 230 to USD 515.
  • The Timken Company: Morgan Stanley upgrades to overweight from equal weight with a price target raised from USD 82 to USD 93.
  • Zimmer Biomet Holdings, Inc.: JP Morgan upgrades to overweight from neutral with a target price raised from USD 125 to USD 128.
  • Dr. Martens Plc: HSBC maintains its hold recommendation with a price target raised from 60 to GBP 85.
  • Sthree Plc: Jefferies maintains its hold recommendation with a price target reduced from 420 to GBX 300.